The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
David C. Wheeler(University College London), Hiddo J.L. Heerspink(University Medical Center Groningen), Robert D. Toto(Southwestern Medical Center), Shin‐Wook Kang(Yonsei University), Anna Maria Langkilde(AstraZeneca (Sweden)), Frederik Persson, Naoki Kashihara(Kawasaki Medical School), Tom Greene(University Medical Center Groningen), Rey Isidto, Walter Douthat, Kausik Umanath(Wayne State University), Magnus Lindberg(University of Gävle), Fan Fan Hou(Southern Medical University), John J.V. McMurray(University of Glasgow), István Wittmann(FIND), David Z.I. Cherney(University Health Network), Glenn M. Chertow(Stanford Health Care), Dinesh Khullar(Max Super Speciality Hospital), Roberto Pecoits‐Filho(Pontifícia Universidade Católica do Paraná), C. David Sjöström(University Medical Center Groningen), Patrick B. Mark(Queen Elizabeth University Hospital), Michał Nowicki(Medical University of Lodz), José Luis Górriz(Universitat de València), Ricardo Correa‐Rotter(University Medical Center Groningen), Hans Furuland(Uppsala University Hospital), Pham Van Bui(Cho Ray Hospital), Jamie P. Dwyer(University of Utah), Bergur V. Stefánsson(University Medical Center Groningen), Peter Rossing(Steno Diabetes Centers), М. М. Батюшин(Rostov State Medical University), Oleksandr Bilchenko(Kharkiv Medical Academy of Postgraduate Education), Elizabeth Escudero, Hermann Haller(Medizinische Hochschule Hannover)
Cited by 189
Related Papers
A New Equation to Estimate Glomerular Filtration Rate
|Annals of Internal Medicine|2009|25.7k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k